Sk Shehan Hossain | Biochemistry, Genetics and Molecular Biology | Young Scientist Award

Published on by Academic Excellence

Young Scientist Award

Sk Shehan Hossain
Regional Institute of Biotechnology, India

Sk Shehan Hossain
Affiliation Regional Institute of Biotechnology
Country India
Documents 3
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Excellence Awards
ORCID 0009-0004-7544-4607

Sk Shehan Hossain is an emerging researcher affiliated with the Regional Institute of Biotechnology, India. His scholarly activities are centered on microbiology, molecular biology, bioinformatics, and computational approaches in biological sciences. Through a combination of molecular characterization and in silico investigations, he has contributed to the documentation of microbial genetic resources and the exploration of biologically active compounds. His research profile demonstrates early-stage scientific productivity supported by publicly accessible datasets and preprint dissemination platforms.[1][3]

Abstract

This article presents an overview of the research profile of Sk Shehan Hossain in the context of the Young Scientist Award. His work includes microbial genetic identification through 16S ribosomal RNA sequencing and computational evaluation of naturally occurring compounds with potential biomedical relevance. The combination of laboratory-supported microbial studies and bioinformatics-based investigations reflects an interdisciplinary approach aligned with contemporary life science research.[2][3]

Keywords

Microbiology, Molecular Biology, Bacillus Species, 16S rRNA Sequencing, Bioinformatics, Computational Biology, Acetylcholinesterase Inhibitor, Biotechnology.

Introduction

Modern biotechnology increasingly integrates experimental and computational methodologies to address biological questions. Researchers working in this domain contribute to microbial characterization, genomic documentation, and the identification of bioactive compounds. Sk Shehan Hossain’s recent works reflect these trends through publicly archived sequence records and computational studies examining therapeutic potential in natural products.[2][3]

Research Profile

The research activities of Sk Shehan Hossain focus on biological characterization, microbial taxonomy, and computational analysis of biologically significant compounds. His profile demonstrates engagement with open scientific repositories and the dissemination of research findings through internationally accessible platforms. The available publications indicate a commitment to generating foundational scientific knowledge within biotechnology and molecular biology.[1]

Research Contributions

  • Documentation of Bacillus cereus strain AKANKSHYAYTB through 16S rRNA gene sequence submission.
  • Identification and reporting of Bacillus safensis strain BISAMLANWB genetic sequence data.
  • Computational evaluation of suaveolic acid as a potential acetylcholinesterase inhibitor.
  • Promotion of open scientific data accessibility through recognized repositories.

Publications

  1. Bacillus cereus strain AKANKSHYAYTB 16S ribosomal RNA gene, partial sequence (NCBI GenBank, 2026).
  2. Bacillus safensis strain BISAMLANWB 16S ribosomal RNA gene, partial sequence (NCBI GenBank, 2026).
  3. In Silico Investigation of Suaveolic Acid from Mesosphaerum suaveolens as an Acetylcholinesterase Inhibitor (Preprint, 2026).

Research Impact

The documented outputs contribute to publicly available scientific resources used by researchers in microbiology and biotechnology. Sequence submissions enrich genomic databases, while computational investigations provide preliminary insights that may support future experimental validation. Such contributions are valuable for advancing reproducibility, accessibility, and collaborative research within the life sciences.[2][3]

Award Suitability

The Young Scientist Award recognizes emerging researchers who demonstrate scientific promise and meaningful scholarly engagement. Based on the available record, Sk Shehan Hossain has established an early research portfolio encompassing molecular biology, microbial genetics, and computational biotechnology. His documented contributions and commitment to open scientific dissemination align with the objectives commonly associated with early-career research recognition programs.[4]

Conclusion

Sk Shehan Hossain represents a developing researcher whose work integrates microbial characterization and computational biological analysis. Through sequence database contributions and bioinformatics-based investigations, he has demonstrated engagement with contemporary scientific methodologies. His academic activities reflect the characteristics of an emerging scientist contributing to biotechnology and molecular biology research.

References

  1. Elsevier. (n.d.). ORCID author details: Sk Shehan Hossain.
  2. NCBI GenBank. (2026). Bacillus cereus strain AKANKSHYAYTB 16S ribosomal RNA gene, partial sequence.
    https://www.ncbi.nlm.nih.gov/nuccore/PZ619927
  3. Zenodo. (2026). In Silico Investigation of Suaveolic Acid from Mesosphaerum suaveolens as an Acetylcholinesterase Inhibitor.
    https://doi.org/10.5281/ZENODO.18837832
  4. International Academic Excellence Awards. (n.d.). Award recognition framework and evaluation criteria.
    academicexcellenceawards.com
  5. NCBI GenBank. (2026). Bacillus safensis strain BISAMLANWB 16S ribosomal RNA gene, partial sequence.
    https://www.ncbi.nlm.nih.gov/nuccore/PZ619164.1/

Kiran Kharsodiya | Immunology | Women Researcher Award

Published on by Academic Excellence

Dr. Kiran Kharsodiya | Immunology | Women Researcher Award

Dr. Kiran Kharsodiya | Immunology | Mody University of Science and Technology | India

Kiran Kharsodiya is a dedicated Research Scientist and Microbiologist with over eight years of experience in clinical, pharmaceutical, and microbiological research. Currently serving as Project Research Scientist II under the ICMR-CAR-MEDTECH Project at St. John’s Research Institute, Bengaluru, Kiran has made impactful contributions in designing and executing large-scale intervention and medical device trials. His expertise lies in microbiological examination, molecular analysis, and the study of host-inflammatory pathways. Kiran holds a strong research background supported by multiple peer-reviewed publications in international journals, reflecting his commitment to advancing medical science. His doctoral research at Mody University focuses on microbiological and molecular analysis of abnormal vaginal discharge and its pathophysiological effects, bridging microbiology and women’s health. A recipient of CSIR-NET qualification in 2024, Kiran exemplifies innovation, critical thinking, and leadership in translational research. His collaborative approach and scientific rigor continue to shape impactful research outcomes with real-world clinical applications.

Author Profiles

Orcid | Google Scholar

Education

Kiran Kharsodiya has pursued a strong academic foundation in microbiology and life sciences, which has shaped his career in biomedical research. He is currently completing his Doctor of Philosophy (PhD) at Mody University, India, where his thesis focuses on “Microbiological Examination and Molecular Analysis in Abnormal Vaginal Discharge and Comparative Analysis of its Pathophysiological Effect.” His PhD integrates molecular biology with clinical microbiology to explore diagnostic and therapeutic strategies in women’s health. Kiran earned his Master of Science (Microbiology) degree from Devi Ahilya University, Indore, India, where he specialized in advanced microbiological techniques and clinical research applications. He also completed a Bachelor of Science (Industrial Microbiology) from the same university, where his academic excellence and research curiosity laid the foundation for his career. Complementing his education, he successfully qualified the prestigious CSIR-NET exam in 2024, showcasing his academic excellence and research potential.

Experience

Currently working as Project Research Scientist II at St. John’s Research Institute, Bengaluru, under the ICMR-CAR-MEDTECH Project (2024–present), Kiran Kharsodiya brings extensive expertise in microbiology and clinical trial management. His role involves designing and executing large-scale pharmaceutical, medical device, and clinical trials, with a focus on ensuring regulatory compliance and high-quality data collection. He actively contributes to Phase III trials, large intervention efficiency studies, and the development of non-medical trial protocols. His ability to coordinate daily operations, collaborate with multidisciplinary teams, and analyze clinical trial data demonstrates his strong leadership in research environments. Kiran is also skilled in publishing and disseminating research findings through scientific journals and conferences, reinforcing his contributions to the broader scientific community. With more than eight years of research experience, he has developed a reputation for innovation, scientific precision, and problem-solving, contributing significantly to advancing biomedical and microbiological research in India and beyond.

Awards and Honors

Throughout his career, Kiran Kharsodiya has consistently demonstrated academic excellence and research dedication, earning several notable distinctions. His most recent achievement includes qualifying the prestigious CSIR-NET examination in 2024, a highly competitive recognition that reflects his advanced scientific knowledge and potential for research leadership. His contributions to translational microbiological and clinical research have also been acknowledged through multiple peer-reviewed publications, a testament to his innovation and dedication. Kiran has been invited to present his findings at national and international scientific conferences, highlighting the global relevance of his work. His collaborative research within multi-institutional projects, such as the ECGRI study on endometriosis and ovarian cancer, further underscores his recognition within the scientific community. These milestones, combined with his proven ability to integrate microbiology, molecular biology, and clinical research, establish him as a promising scientist whose work continues to be recognized for both academic rigor and societal impact.

Research Focus

Kiran Kharsodiya’s research focus lies at the intersection of microbiology, immunology, and women’s health. His PhD work emphasizes microbiological examination and molecular analysis of abnormal vaginal discharge, aiming to identify pathogenic flora, host-inflammatory responses, and their pathophysiological effects. This contributes to better diagnostic and therapeutic strategies for gynecological conditions. His studies also expand into the role of biomarkers, such as cytokines and microRNAs, in diseases like endometriosis and ovarian cancer, highlighting his interest in translational research. By integrating clinical microbiology, immunological pathways, and molecular diagnostics, Kiran seeks to improve early detection and intervention in reproductive health disorders. His work extends to exploring host-pathogen interactions, inflammation markers such as IL-6, IL-1β, TNF-α, and their predictive value in microbial infections. This research bridges fundamental microbiology with clinical applications, addressing pressing healthcare challenges. His long-term goal is to advance diagnostic tools and contribute meaningfully to global women’s healthcare solutions.

Publications

  • Protocol for a case–control study investigating the clinical phenotypes and genetic regulation of endometriosis in Indian women: the ECGRI study.

  • The relationship between melatonin 1-2 receptor expression in patients with epithelial ovarian cancer and survival.

  • Endometriosis in India: Analysing diagnostic delays, geographic variations, clinical phenotypes and associated characteristics from the ECGRI Study.

  • Predictive value of IL-6, IL-1β, TNF-α, and vaginal pH in diagnosing vaginal microbial infections: A host-inflammatory axis perspective.

  • Identification and characterization of pathogenic microbial flora associated with abnormal vaginal discharge: A microbiological examination study.

  • A pilot study of circulating microRNA-125b as a diagnostic & prognostic biomarker for epithelial ovarian cancer.

  • 2022-RA-195-ESGO miRNA-125b expression in epithelial ovarian cancer.

Conclusion

Kiran Kharsodiya is a dynamic researcher with strong expertise in microbiology, immunology, and clinical research, making significant contributions to women’s health and translational medicine. His blend of academic rigor, practical experience in large-scale trials, and impactful publications positions him as a promising leader in biomedical sciences. With a clear focus on innovation, collaboration, and clinical relevance, he continues to advance knowledge at the crossroads of microbiology and immunology, striving to improve diagnostic and therapeutic outcomes for global healthcare.